2006
DOI: 10.1016/j.jaad.2006.08.001
|View full text |Cite
|
Sign up to set email alerts
|

Acremonium mycetoma in a heart transplant recipient

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
22
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(22 citation statements)
references
References 38 publications
0
22
0
Order By: Relevance
“…The genus Acremonium currently contains approximately 100 species, and many are recognized as opportunistic pathogens of humans and animals, causing mycetoma, onychomycosis, and hyalohyphomycosis [19][21]. Clinical manifestations of hyalohyphomycosis that are caused by Acremonium include arthritis, osteomyelitis, peritonitis, endocarditis, pneumonia, cerebritis and subcutaneous infection [19].…”
Section: Discussionmentioning
confidence: 99%
“…The genus Acremonium currently contains approximately 100 species, and many are recognized as opportunistic pathogens of humans and animals, causing mycetoma, onychomycosis, and hyalohyphomycosis [19][21]. Clinical manifestations of hyalohyphomycosis that are caused by Acremonium include arthritis, osteomyelitis, peritonitis, endocarditis, pneumonia, cerebritis and subcutaneous infection [19].…”
Section: Discussionmentioning
confidence: 99%
“…Response to medical treatment is usually better in actinomycetoma than eumycetoma, which is difficult to treat with current therapies. [4]…”
Section: Introductionmentioning
confidence: 99%
“…Itraconazoie has been found to exhibit in vitro activity against Alternarla, but treatment failures with the compound have been reported (It). As more potent immunosuppressive drugs become available to prevent graft rejection, survival increases, expanding the population of immunocompromised patients and increasing the number of patients with opportunistic infections involving the skin (15). Voriconazole has been shown to be an efficient alternative to amphotericin B and surgical debridement for the treatment of cutaneous A. alternata infection in a liver transplant patient (14).…”
Section: Discussionmentioning
confidence: 99%